AIBP regulates TRPV1 activation in CIPN by controlling lipid raft dynamics and proximity to TLR4 in DRG neurons.

Nociceptive afferent signaling evoked by inflammation and nerve injury is mediated by the opening of ligand- and voltage-gated receptors/channels localized to cholesterol-rich lipid raft membrane domains. Dorsal root ganglia (DRG) nociceptors express high levels of toll-like receptor 4 (TLR4), which also localize to lipid rafts. Genetic deletion or pharmacologic blocking of TLR4 diminishes pain associated with chemotherapy-induced peripheral neuropathy (CIPN). In DRGs of mice with paclitaxel-induced CIPN, we analyzed DRG neuronal lipid rafts, expression of TLR4, activation of transient receptor potential cation channel subfamily V member 1 (TRPV1) and TLR4-TRPV1 interaction. Using proximity ligation assay (PLA), flow cytometry, and whole-mount DRG microscopy, we found that CIPN increased DRG neuronal lipid rafts and TLR4 expression. These effects were reversed by intrathecal injection of apolipoprotein A-I binding protein (AIBP), a protein that binds to TLR4 and specifically targets cholesterol depletion from TLR4-expressing cells. CIPN increased TRPV1 phosphorylation, localization to neuronal lipid rafts and proximity to TLR4. These effects were also reversed by AIBP treatment. AIBP regulation of TRPV1-TLR4 interactions and their associated lipid rafts covaried with the enduring reversal of mechanical allodynia otherwise observed in CIPN. AIBP reduced intracellular calcium in response to the TRPV1 agonist capsaicin, which was increased in DRG neurons from paclitaxel treated mice and in the naïve mouse DRG neurons incubated in vitro with paclitaxel. Together, these results suggest that the assembly of nociceptive and inflammatory receptors in the environment of lipid rafts regulates nociceptive signaling in DRG neurons and that AIBP can control lipid raft-associated nociceptive processing.